Cerevance is a clinical-stage biopharmaceutical company developing novel therapeutics for central nervous system (CNS) disorders. Its proprietary NETSseq platform profiles gene expression across specific human brain cell types from post-mortem tissue to identify previously undiscovered, cell-type-specific drug targets, powering a pipeline of… - View it on GitHub